Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D04VQH
|
||||
Former ID |
DIB005010
|
||||
Drug Name |
XEN-D0501
|
||||
Synonyms |
XEN-D501; Ion channel modulator 1 (overactive bladder), Xention; TRPV1 antagonist (overactive bladder), Xention;VR1 antagonist (overactive bladder), Xention; Vanilloid receptor-1 antagonist (overactive bladder), Xention; Ion channel modulator (overactive bladder), Xention/Scion/Bristol-Myers Squibb
|
||||
Indication | Overactive bladder disorder [ICD9: 188, 596.51; ICD10:C67, N32.81] | Phase 2 | [524905] | ||
Company |
Bristol-Myers Squibb Co
|
||||
Target and Pathway | |||||
Target(s) | Vanilloid receptor 1 | Target Info | Antagonist | [531517] | |
NetPath Pathway | IL2 Signaling Pathway | ||||
Pathway Interaction Database | Trk receptor signaling mediated by the MAPK pathway | ||||
Trk receptor signaling mediated by PI3K and PLC-gamma | |||||
Reactome | TRP channels | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.